title: Interview with Paul Selzer.
abstract: Paul Selzer, a computational chemist at Novartis (Basel, Switzerland), has been part of the computational medicinal chemistry field for over 20 years. Prior to joining Novartis in 1999, Selzer gained his PhD in computational chemistry from the University of Erlangen-Nuremberg (Erlangen, Germany) before working as a postdoctoral researcher. Selzer has authored a number of high-impact publications in the field and in this interview with Future Medicinal Chemistry, discusses some of the pressing issues in the computational medicinal chemistry arena, current work being conducted by the research group at Novartis, and more. Interview conducted by James Potticary, Assistant Commissioning Editor.
authors.affiliation: Novartis Institutes for Biomedical Research, Basel, Switzerland. paul.selzer@novartis.com.
authors.forename: Paul
authors.initials: P
authors.lastname: Selzer
authors.forename: James
authors.initials: J
authors.lastname: Potticary
mesh_terms: D002626:Chemistry, Pharmaceutical; D019295:Computational Biology / Q000379:methods; D017076:Computer-Aided Design; D055808:Drug Discovery / Q000379:methods; D006801:Humans; D012106:Research